Clinical Trial

Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluate the efficacy and safety of Jia Shen Tablets in patients with Chronic Heart Failure.
Trial Details
NCT Number NCT06669169
Lead Sponsor Tasly Pharmaceutical Group Co., Ltd
Conditions Heart Failure
Enrollment 288 participants
Start Date 2025-01-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-01